ARTICLE | Clinical News
Celgene regulatory update
March 18, 1996 8:00 AM UTC
CELG received European Patent No. 404,146 covering the use of its biocatalysis technology in producing chiral amines. Chiral amines are a class of chemical compounds used in agrichemicals, artificial ...